Ratio Examination: Jaguar Health Inc (JAGX)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Jaguar Health Inc (NASDAQ: JAGX) closed at $1.08 down -4.42% from its previous closing price of $1.13. In other words, the price has decreased by -$4.42 from its previous closing price. On the day, 0.57 million shares were traded. JAGX stock price reached its highest trading level at $1.2 during the session, while it also had its lowest trading level at $1.07.

Ratios:

For a deeper understanding of Jaguar Health Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 2.10. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.17.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.

On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, JAGX now has a Market Capitalization of 10442596 and an Enterprise Value of 30244530. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.98 while its Price-to-Book (P/B) ratio in mrq is 0.50. Its current Enterprise Value per Revenue stands at 2.97 whereas that against EBITDA is -1.028.

Stock Price History:

Over the past 52 weeks, JAGX has reached a high of $30.86, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -7.95%, while the 200-Day Moving Average is calculated to be -76.84%.

Shares Statistics:

For the past three months, JAGX has traded an average of 367.19K shares per day and 289020 over the past ten days. A total of 9.24M shares are outstanding, with a floating share count of 7.71M. Insiders hold about 16.61% of the company’s shares, while institutions hold 1.11% stake in the company. Shares short for JAGX as of 1728950400 were 139411 with a Short Ratio of 0.38, compared to 1726185600 on 370657. Therefore, it implies a Short% of Shares Outstanding of 139411 and a Short% of Float of 1.50999995.

Most Popular